Cronos inks deal to buy cannabis MSO PharmaCann stake for $110 million
A subsidiary of Toronto-based Cronos Group purchased an option to acquire approximately 10.5% of PharmaCann, one of the…
News June 14
Latest In: Cronos
Cannabis firm Cronos’ CEO gets CA$12 million-plus in partial-year pay
Canadian cannabis producer Cronos Group paid CEO Kurt Schmidt more than $10 million (12.2 million Canadian dollars) in…
News May 10
Cronos reports $161 million net loss on cannabis revenue of $12.6 million in Q1
Canadian cannabis producer Cronos reported a net loss of $161 million (195 million Canadian dollars) for its January-March…
News May 7
Aurora Cannabis leads Canada in market share decline while smaller companies gain, report says
Aurora Cannabis surrendered a greater share of Canada’s recreational market last year compared to rival licensed producers –…
News April 13
Cannabis producer Cronos loses $111.7 million in fourth quarter
Canadian cannabis producer Cronos Group reported a quarterly loss of $111.7 million and an adjusted EBITDA of negative…
News February 26
Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?
Jazz Pharmaceuticals' planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making…
News February 5
Cannabis producer Cronos reports higher revenue in third quarter
Canadian cannabis producer Cronos Group reported improved revenue for its latest quarter ended Sept. 30.
News November 5
Week in Review: Nature’s huge toll on cannabis growers, Illinois social equity questions, legalization efforts & more
Wildfires in the West have devastated a number of marijuana farms in Oregon, Washington state and California, while…
News September 12
Canadian cannabis firm Cronos posts $31.3M operating loss in Q2
Toronto-based cannabis company Cronos Group reported an adjusted operating loss of $31.3 million for its second quarter, along…
News August 6Featured
1
Latest Sponsored
